Literature DB >> 18296549

Tumor-volume changes after radiosurgery for vestibular schwannoma: implications for follow-up MR imaging protocol.

O W M Meijer1, E J Weijmans, D L Knol, B J Slotman, F Barkhof, W P Vandertop, J A Castelijns.   

Abstract

BACKGROUND AND
PURPOSE: The outcome of radiosurgery for vestibular schwannoma (VS) is assessed by posttreatment measurement of tumor size and could be influenced by the timing and quality of the assessment. This study evaluates the volumetric changes of VS after radiosurgery and proposes a radiologic follow-up program.
MATERIALS AND METHODS: Of 142 patients with VS treated with radiosurgery, we selected patients who were followed at least 3 times during a minimum of 32 months with a T1-weighted gadolinium-enhanced high-resolution 3D MR imaging examination identical to the pretreatment MR imaging. Forty-five patients were identified with a mean follow-up of 50 months (range, 32-78 months). Pre- and posttreatment tumor volumes were calculated by using BrainSCAN software by manually contouring tumors on each MR imaging study. Volume changes of >13% were defined as events.
RESULTS: At last follow-up MR imaging, volumes were smaller in 37 (82.2%) of the 45 patients. Eleven (29.7%) of these 37 tumors showed transient swelling preceding regression, with a median time to regression of 34 months (range, 20-55 months). Seven (15.6%) of the 45 tumors had volume progression compared with the tumor on pretreatment MR imaging studies. Of these 7 tumors, 3, however, had volume regression compared with the preceding MR imaging study, and in 4, volume progression was ongoing. One tumor remained the same.
CONCLUSIONS: Tumor-volume measurements by standardized T1-weighted gadolinium-enhanced high-resolution 3D MR imaging follow-up protocols revealed good local control of VS after radiosurgery. The first-follow-up MR imaging at 2 years and the second at 5 years postradiosurgery differentiated transient progression from ongoing progression and may prevent unnecessary therapeutic interventions.

Entities:  

Mesh:

Year:  2008        PMID: 18296549      PMCID: PMC8128568          DOI: 10.3174/ajnr.A0969

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  28 in total

1.  Fractionated stereotactic radiotherapy for acoustic neuromas: preservation of function versus size.

Authors:  Jeffery A Williams
Journal:  J Clin Neurosci       Date:  2003-01       Impact factor: 1.961

2.  Fractionated stereotactic radiation therapy and single high-dose radiosurgery for acoustic neuroma: early results of a prospective clinical study.

Authors:  O W Meijer; J G Wolbers; J C Baayen; B J Slotman
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-01-01       Impact factor: 7.038

3.  Stereotactic and microsurgery for acoustic neuroma: the controversy continues.

Authors:  Antonio A F De Salles; Leonardo Frighetto; Michael Selch
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-08-01       Impact factor: 7.038

4.  Single-fraction vs. fractionated linac-based stereotactic radiosurgery for vestibular schwannoma: a single-institution study.

Authors:  O W M Meijer; W P Vandertop; J C Baayen; B J Slotman
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-08-01       Impact factor: 7.038

5.  Committee on Hearing and Equilibrium guidelines for the evaluation of results of treatment of conductive hearing loss. AmericanAcademy of Otolaryngology-Head and Neck Surgery Ffoundation, Inc.

Authors: 
Journal:  Otolaryngol Head Neck Surg       Date:  1995-09       Impact factor: 3.497

6.  Using Bayesian tissue classification to improve the accuracy of vestibular schwannoma volume and growth measurement.

Authors:  Elizabeth A Vokurka; Amit Herwadkar; Neil A Thacker; Richard T Ramsden; Alan Jackson
Journal:  AJNR Am J Neuroradiol       Date:  2002-03       Impact factor: 3.825

7.  Laryngeal tumor volume measurements determined with CT: a study on intra- and interobserver variability.

Authors:  R Hermans; M Feron; E Bellon; P Dupont; W Van den Bogaert; A L Baert
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-02-01       Impact factor: 7.038

8.  Increased preservation of functional hearing after gamma knife surgery for vestibular schwannoma.

Authors:  Albertus T C J van Eck; Gerhard A Horstmann
Journal:  J Neurosurg       Date:  2005-01       Impact factor: 5.115

9.  Fractionated stereotactic radiotherapy for acoustic neuromas.

Authors:  Jeffery A Williams
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-10-01       Impact factor: 7.038

10.  Volume growth rate of acoustic neurinomas.

Authors:  E M Laasonen; H Troupp
Journal:  Neuroradiology       Date:  1986       Impact factor: 2.804

View more
  30 in total

1.  The impact of MRI steady-state sequences as an additional assessment modality in vestibular schwannoma patients after LINAC stereotactic radiotherapy or radiosurgery.

Authors:  Julian P Sauer; Thomas M Kinfe; Bogdan Pintea; Andreas Schäfer; Jan P Boström
Journal:  Strahlenther Onkol       Date:  2018-05-23       Impact factor: 3.621

2.  3D quantitative assessment of response to fractionated stereotactic radiotherapy and single-session stereotactic radiosurgery of vestibular schwannoma.

Authors:  T Schneider; J Chapiro; M Lin; J F Geschwind; L Kleinberg; D Rigamonti; I Jusué-Torres; A E Marciscano; D M Yousem
Journal:  Eur Radiol       Date:  2015-07-03       Impact factor: 5.315

Review 3.  [Imaging-based diagnosis of vestibular schwannoma].

Authors:  C Strasilla; V Sychra
Journal:  HNO       Date:  2017-05       Impact factor: 1.284

4.  [Stereotactic radiosurgery and fractionated stereotactic radiotherapy of acoustic neuromas].

Authors:  F Unger; K Dominikus; K Haselsberger
Journal:  HNO       Date:  2011-01       Impact factor: 1.284

5.  Follow-up MR findings of spinal foraminal nerve sheath tumors after stereotactic irradiation.

Authors:  Hyo Jin Kang; Yoon Joon Hwang; Yong Hoon Kim; Su Young Kim; Byung Hoon Lee; Moon-Jun Sohn
Journal:  Jpn J Radiol       Date:  2012-12-20       Impact factor: 2.374

Review 6.  Imaging changes following stereotactic radiosurgery for metastatic intracranial tumors: differentiating pseudoprogression from tumor progression and its effect on clinical practice.

Authors:  Jacob Ruzevick; Lawrence Kleinberg; Daniele Rigamonti
Journal:  Neurosurg Rev       Date:  2013-11-15       Impact factor: 3.042

7.  Comparison of stereotactic radiosurgery and fractionated stereotactic radiotherapy of acoustic neurinomas according to 3-D tumor volume shrinkage and quality of life.

Authors:  Martin Henzel; Klaus Hamm; Helmut Sitter; Markus W Gross; Gunnar Surber; Gabriele Kleinert; Rita Engenhart-Cabillic
Journal:  Strahlenther Onkol       Date:  2009-09-12       Impact factor: 3.621

Review 8.  Suggested response criteria for phase II antitumor drug studies for neurofibromatosis type 2 related vestibular schwannoma.

Authors:  Scott R Plotkin; Chris Halpin; Jaishri O Blakeley; William H Slattery; D Bradley Welling; Susan M Chang; Jay S Loeffler; Gordon J Harris; A Gregory Sorensen; Michael J McKenna; Fred G Barker
Journal:  J Neurooncol       Date:  2009-05-09       Impact factor: 4.130

9.  EANO guideline on the diagnosis and treatment of vestibular schwannoma.

Authors:  Roland Goldbrunner; Michael Weller; Jean Regis; Morten Lund-Johansen; Pantelis Stavrinou; David Reuss; D Gareth Evans; Florence Lefranc; Kita Sallabanda; Andrea Falini; Patrick Axon; Olivier Sterkers; Laura Fariselli; Wolfgang Wick; Joerg-Christian Tonn
Journal:  Neuro Oncol       Date:  2020-01-11       Impact factor: 12.300

10.  Follow-up assessment of vestibular schwannomas: volume quantification versus two-dimensional measurements.

Authors:  Rick van de Langenberg; Bert Jan de Bondt; Patty J Nelemans; Brigitta G Baumert; Robert J Stokroos
Journal:  Neuroradiology       Date:  2009-05-06       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.